PD-L1 ImagiNg to prediCt Durvalumab Treatment Response in HNSCC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Durvalumab
Related studies linked through entity extraction aliases.
hARnessing CAbozantinib and Durvalumab Immuno-oncology Association: ARCADIA Study"
- Status
- UNKNOWN
- Phase
- PHASE2
Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Proton Based Cardiac Sparing Accelerated Fractionated RadioTherapy in Unresectable NSCLC
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
A Study of Olaparib and Durvalumab in Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Immunotherapy Combined With Y-90 and SBRT for Colorectal Liver Metastases
- Status
- WITHDRAWN
- Phase
- PHASE1
Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 Trial
- Status
- COMPLETED
- Phase
- PHASE1
AMTEC IIT: Phase 2 Multiarm Study in TNBC
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1
Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
This Study is a Phase II Study of AZD6738 in Combination With Durvalumab in Patients With Solid Tumor (Cohort A (N=30): GC Who Have Failed Secondary Chemotherapy Treatments Regimen; Cohort B (B=30): Melanoma Patients Who Have Failed to IO)
- Status
- UNKNOWN
- Phase
- PHASE2
A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Feasibility Study of Durvalumab +/- Oleclumab as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer (BLASST-2)
- Status
- COMPLETED
- Phase
- PHASE1
Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2